Kelvyn has three decades experience as a medtech CEO, over a decade on the board of the Medical Device Manufacturers Association and over a decade as mayor of a suburb of Salt Lake City. He brings a unique understanding of industry and policy issues to advance association objectives and help member companies. He has been CEO of BioUtah since October 2018.

Jacey Skinner has held a variety of senior leadership roles in Utah state government and Utah business organizations. Before joining Ballard Spahr, served as General Counsel to Utah Gov. Gary Herbert from 2013 to 2017. In that role, she negotiated legislation, oversaw the Governor's legislative review and bill signing, coordinated litigation with the Attorney General's Office, advised the Governor, his Cabinet, and the Lieutenant Governor on legal, policy, and ethical issues, and oversaw Gov. Herbert's judicial appointment process. She also served as the Deputy State Court Administrator for the State of Utah, where she facilitated policy development and managed relations with the state legislature, executive branch agencies, the Utah Judicial Council, and the Utah Supreme Court.

Dr. Haven McCall has 24 years of experience working in the medical device, drug and biologics industry in various roles including, scientific, technical, regulatory, quality, and clinical research. He currently serves as the Founder and CEO of Novo Laboratories, LLC headquartered in Lehi, Utah. Haven is passionate about science and innovation and enjoys working within Utah's thriving life science industry.

Haven's doctoral studies at the University of Southern California focused on improving the standard of care for patients through risk mitigation and quality principles. His personal mission throughout his career has been on developing innovative products that have life changing benefits for the patients who use them. 

Haven is a member of BioUtah, Regulatory Affairs Professionals Society (RAPS), American Society for Quality (ASQ), Project Management Institute (PMI), The Organization for Professionals in Regulatory Affairs (TOPRA - Europe) and the Collaborative Institutional Training Initiative (CITI Program), Society of Clinical Research Associates (SOCRA). Over the last 20 years, he has participated within these organizations to drive improvements for industry best practices, regulations, guidance documents, standards and directives.

Throughout his career, Haven has also taught graduate level courses in quality, regulatory and clinical research and currently teaches at Johns Hopkins University.